Rocket Lab becomes a space giant with Iridium buyout — ride the momentum on RKLB

Verdict: Let Rocket Lab Prove the Breakout Before Chasing the $8B Iridium Deal

The strongest case for this trade is structural: Rocket Lab pairs a debt-free balance sheet — $828.7M of cash against just $1.7M of long-term debt — with accelerating standalone growth (revenue up 16.8% quarter-over-quarter to $234.1M), and Iridium brings exactly the high-margin cash engine RKLB lacks, with a 27.1% operating margin in the 92nd peer percentile and $299.8M of free cash flow. The strongest case against is behavioral and cash-flow-based: insiders at both companies were net open-market sellers (roughly $348.3M at RKLB per the ownership filing as of June 30, 2026, which also arrived after its deadline with only four holders reporting), and RKLB's free cash flow worsened 42% quarter-over-quarter to negative $110.1M in the quarter ended June 30, 2026. The momentum entry is also not yet live — the last close of $67.00 has not crossed the $67.39 resistance line, and the OBV condition is unverifiable on the current feed — so this remains a watch-list setup rather than a confirmed signal. What would flip the verdict toward buying is a confirmed daily close above $67.39 with the volume condition satisfied on a completed bar; what would flip it against is a close below the $66.92 support or a worsening cash-flow print in the September-quarter report due around October.

Trade now: RKLB is one strong close away from an entry — do not chase yet

This is a watch-list setup, not an active signal: the rules have been evaluated on real daily bars and have not opened an entry yet, so today's job is to be ready rather than to buy. The live read on RKLB is encouraging — the one-day rate of change is 4.26% against a 3% threshold (met), and the trend-strength measure reads 59.2 against a 20 floor (met). Two conditions remain unresolved: on-balance volume could not be computed on the live feed, and the close at $67.00 has not crossed above the first resistance level at $67.39. The IRDM leg is further away — its one-day change is 1.06%, about 1.9 points below its 3% trigger, with the close at $47.71 below its $48.00 resistance line. If the RKLB entry fires on a close above $67.39, the plan is mechanical: the hard stop sits at a 2.3% loss on the position (roughly $65.55 from that entry), and the first take-profit sits at a 4.6% gain (roughly $68.74). An alternative exit closes the trade if a close lands below the nearest support at $66.92. That makes the effective reward-to-risk about 2-to-1 on the fixed percentage exits — modest size is appropriate given RKLB's 61% maximum drawdown over the past two years. "Wait" means concretely: place no order today, but set an alert at $67.39 on RKLB and re-check the volume condition on the next completed daily bar. If RKLB gaps above the line, let the close confirm rather than buying the open — a failed breakout through $67.39 would put the thesis's momentum case on hold, not on hold indefinitely, since the strategy simply needs its conditions to line up on a single daily bar.

A cash-rich acquirer just bought itself a dividend-paying cash machine

The idea argues that Rocket Lab's $8 billion acquisition of Iridium (announced June 29, 2026, per CNBC) vertically integrates launch with an operating satellite network — and the balance-sheet numbers make that combination plausible. Rocket Lab ended fiscal 2025 with $828.7M in cash against just $1.7M of long-term debt, and its leverage has continued to fall: debt-to-equity dropped from 0.0008 at the end of Q1 2026 to 0.0005 at the end of Q2 2026. This is an acquirer with enormous optionality and essentially no leverage. The asset being bought is exactly the kind of business Rocket Lab lacks. Iridium's fiscal 2025 fundamentals show $871.7M in revenue (up 4.9% year over year), a 27.1% operating margin that ranks in the 92nd percentile of Communication Services peers, $299.8M of free cash flow (82nd percentile), and a 24.7% return on equity. Rocket Lab, by contrast, posted a -28.4% operating margin in fiscal 2025. Layering a high-margin, cash-generative subscription business onto a high-growth launch business is the structural logic of the deal, and the numbers back the thesis's framing. Rocket Lab's standalone growth engine is also intact going into the combination: quarterly revenue climbed from $200.3M in Q1 2026 to $234.1M in Q2 2026, a 16.8% sequential gain, on top of fiscal 2025 growth of 69.1% year over year — the 87th percentile among Industrials peers. Gross margin has been grinding upward, from 34.4% in fiscal 2025 to 36.1% in Q2 2026, and the trailing operating margin has improved from -38.0% to -24.6% over the same span. The margin trajectory supports the argument that scale plus Iridium's cash flows could compress the…

Scores

• Conviction score breakdown: 58
• Thesis support: 70
• Trade readiness: 55
• Risk quality: 45
• Trigger proximity: 60
• Fundamentals trend: 62

Watch items

• RKLB — Daily close vs first resistance
• RKLB — ROC (1)
• RKLB — OBV
• RKLB — Close vs nearest support
• IRDM — ROC (1)
• IRDM — Close vs first resistance
• RKLB — Free cash flow, quarterly
• RKLB — Insider open-market activity
• IRDM — Next dividend ex-date